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Abstract. 
 
Recent studies have demonstrated the im-
portance of E-cadherin, a homophilic cell–cell adhesion 
molecule, in contact inhibition of growth of normal 
epithelial cells. Many tumor cells also maintain strong 
intercellular adhesion, and are growth-inhibited by cell–
cell contact, especially when grown in three-dimen-
sional culture. To determine if E-cadherin could mediate 
contact-dependent growth inhibition of nonadherent 
EMT/6 mouse mammary carcinoma cells that lack 
E-cadherin, we transfected these cells with an exoge-
nous E-cadherin expression vector. E-cadherin expres-
sion in EMT/6 cells resulted in tighter adhesion of mul-
ticellular spheroids and a reduced proliferative fraction 
in three-dimensional culture. In addition to increased 
cell–cell adhesion, E-cadherin expression also resulted in 
dephosphorylation of the retinoblastoma protein, an 
increase in the level of the cyclin-dependent kinase 
 
inhibitor p27
 
kip1
 
 and a late reduction in cyclin D1 pro-
tein. Tightly adherent spheroids also showed increased 
levels of p27 bound to the cyclin E-cdk2 complex, and a 
reduction in cyclin E-cdk2 activity. Exposure to E-cad-
herin–neutralizing antibodies in three-dimensional cul-
ture simultaneously prevented adhesion and stimulated 
proliferation of E-cadherin transfectants as well as a 
panel of human colon, breast, and lung carcinoma cell 
lines that express functional E-cadherin. To test the 
importance of p27 in E-cadherin–dependent growth in-
hibition, we engineered E-cadherin–positive cells to ex-
press inducible p27. By forcing expression of p27 levels 
similar to those observed in aggregated cells, the stim-
ulatory effect of E-cadherin–neutralizing antibodies 
on proliferation could be inhibited. This study demon-
strates that E-cadherin, classically described as an in-
vasion suppressor, is also a major growth suppressor, 
and its ability to inhibit proliferation involves upregu-
lation of the cyclin-dependent kinase inhibitor p27.
Key words: E-cadherin • p27 • kip1 • cyclin D • epi-
dermal growth factor receptor 
 
I
 
ntercellular
 
 adhesion molecules and extracellular
matrix (ECM),
 
1
 
 once viewed simply as cellular glue
and mechanical scaffolding, are now known to have
profound effects on cell behavior (Juliano and Haskill,
1993). For example, interactions between integrins and
ECM promote the growth and survival of many cell lines
in culture (Meredith and Schwartz, 1997; Bottazzi and As-
soian, 1997). In addition, intercellular adhesion molecules
have been shown to be necessary for nontransformed cells
growing in monolayer tissue culture to become quiescent
when they reach confluence by a process known as contact
inhibition (Aoki et al., 1991; Takahashi and Suzuki, 1996;
Kandikonda et al., 1996). Although much has been
learned recently about the mechanisms by which cell–
ECM interactions promote growth (Assoian, 1997; Bot-
tazzi and Assoian, 1997), much less is known about the
molecular pathways by which homophilic cell–cell interac-
tions inhibit cell cycle progression.
Many tumor cell lines are subject to contact-dependent
growth inhibition, although not to the same degree as nor-
mal cells. Because solid tumors usually grow as three-
dimensional masses, our laboratory has been interested in
understanding the impact of cellular aggregation on the
growth properties of cells. By growing cells in three-
dimensional culture, we observed a greater degree of con-
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tact-dependent growth inhibition than could be observed
in confluent vs. subconfluent monolayer cultures. We also
observed, using clonally derived variants of the EMT/6
mouse mammary carcinoma cell line, that the rate of pro-
liferation in three-dimensional culture depended largely
on the degree of intercellular adhesion, since spontane-
ously nonadherent variant cell lines incorporated signifi-
cantly more bromodeoxyuridine than did tightly-adherent
cell lines (St. Croix et al., 1996
 
b
 
). Although the precise
mechanism controlling intercellular adhesion in tightly-
adherent EMT/6 variant cell lines is yet unknown, adding
hyaluronidase could abolish such adhesion; we therefore
refer to this adhesion mechanism as hyaluronic acid (HA)-
dependent. Furthermore, tightly-adherent variants dis-
persed with hyaluronidase grew at a rate similar to that
observed for loosely-adherent EMT/6 variants.
The recent identification of several key regulators of cell
cycle progression provides a valuable new avenue for de-
lineating the molecular mechanisms underlying contact in-
hibition. The cell cycle is governed by sequential activa-
tion and inactivation of a family of cyclin-dependent
kinases (cdks; Morgan, 1995). Cdk activation requires cy-
clin association, and cyclin levels typically oscillate
throughout the cell cycle. Because contact-inhibited cells
enter quiescence or the G1/G0 phase of the cell cycle, mol-
ecules regulating G0/G1-phase are likely to be particularly
important for understanding contact inhibition. Progres-
sion through G1 into S-phase is regulated by D-type cy-
clins associated with cdk4 or cdk6, and by cyclin E-cdk2.
Subsequently, as cells enter S phase, cyclin A-cdk2 is acti-
vated. Recently two families of cyclin-dependent kinase
inhibitors (CKIs) have been identified that bind to and in-
hibit the activity of cdks (Sherr and Roberts, 1995). The
INK4 family is comprised of p15
 
INK4B
 
, p16
 
INK4A
 
, p18
 
INK4C
 
,
and p19
 
INK4D
 
. INK4 family members share four ankyrin
motifs and specifically inhibit cyclin D–dependent cdks
(cdk4 and cdk6). Three KIP family members have also
been identified, and include p21
 
CIP1/WAF1
 
, p27
 
KIP1
 
, and
p57
 
KIP2
 
. Members of this family show broader substrate
specificity, and inhibit the activity of both cyclin D-cdk4/6
and cyclin E-cdk2. Because levels and/or activity of p27
are elevated upon cell–cell contact of nontransformed fi-
broblasts or epithelial cells (Hengst et al., 1994; Slinger-
land et al., 1994; Polyak et al., 1994; Winston et al., 1996;
Kato et al., 1997), this inhibitor may be of particular im-
portance in regulating contact inhibition. Similarly, our re-
cent studies demonstrate that p27 levels increase when
breast, colon, and ovarian carcinoma cell lines are trans-
ferred from two- to three-dimensional culture. Impor-
tantly, depleting p27 from tumor cells using an antisense
strategy resulted in significant growth stimulation, but
only in three-dimensional culture (St. Croix et al., 1996
 
a
 
).
Therefore, p27 is at least in part responsible for contact-
dependent growth inhibition of carcinoma cells. However,
normal fibroblasts from p27
 
2
 
/
 
2
 
 mice undergo contact in-
hibition (Nakayama et al., 1996) suggesting that there may
be cell type specificity or redundancy in the regulation of
contact inhibition at the molecular level.
Although p27 levels have been temporally correlated
with cell–cell contact, the ability of homophilic cell adhe-
sion molecules to regulate signaling pathways that impinge
upon p27 levels has not been fully investigated. In this
study, we analyzed the effect of E-cadherin on both prolif-
eration and p27 levels. E-cadherin is a major calcium-depen-
dent homophilic cell adhesion molecule found on normal
epithelial cells. Its intracellular domain binds directly to
 
b
 
-catenin which, along with 
 
a
 
-catenin, links E-cadherin to
the underlying actin cytoskeleton (Aberle et al., 1996). In
addition to its role in adhesion, 
 
b
 
-catenin has also been im-
plicated in 
 
Wnt
 
 signal transduction, and interacts with the
APC tumor suppressor protein as well as transcription fac-
tors of the LEF/TCF family (Behrens et al., 1996; Mo-
lenaar et al., 1996; Huber et al., 1996; Su et al., 1993; Ru-
binfeld et al., 1993). By sequestering 
 
b
 
-catenin at the cell
surface, cadherins have been shown to antagonize 
 
b
 
-cate-
nin signaling pathways which are required for normal dor-
soventral axis formation in 
 
xenopus
 
 (Fagotto et al., 1996).
In many carcinomas, cadherins or catenins are lost or
downregulated, resulting in a reduced level of intercellular
adhesion (Becker et al., 1994; Berx et al., 1996). Loss of
E-cadherin function may endow tumor cells with a relative
growth advantage over normal contact-inhibited cells. In-
deed, several studies have suggested a potential role for
E-cadherin as a growth suppressor (Hermiston and Gor-
don, 1995
 
b
 
; Miyaki et al., 1995; Navarro et al., 1991; Taka-
hashi and Suzuki, 1996; Kandikonda et al., 1996; Watabe
et al., 1994). However, the mechanism(s) by which E-cad-
herin affects the cell cycle machinery have not been eluci-
dated.
In the present study we investigated the role of E-cad-
herin in contact-dependent growth inhibition of carcinoma
cells, and analyzed potential cell cycle molecules regulated
by cadherin-mediated adhesion. Carcinoma cells that
maintain E-cadherin function were growth inhibited by
cell–cell contact when grown in a three-dimensional con-
text. Importantly, the cyclin-dependent kinase inhibitor
p27 was increased in E-cadherin–arrested cellular aggre-
gates to levels sufficient to saturate and inhibit cyclin
E-cdk2 complexes. One mechanism by which E-cadherin
can elevate p27 is through inhibition of mitogenic signal-
ing pathways initiated from receptor tyrosine kinases
(RTKs) such as the epidermal growth factor receptor
(EGFR). Our results suggest that E-cadherin is not only
an invasion suppressor (Vleminckx et al., 1991), but also a
proliferation suppressor, and its ability to suppress prolif-
eration depends on its ability to prevent growth factor in-
duced reduction in p27 protein levels.
 
Materials and Methods
 
Cell Lines and Culture Conditions
 
The human MCF-7 breast carcinoma cell line and the murine EMT/6
mammary carcinoma cell line were a gift from Dr. Beverly Teicher (Dana-
Farber Cancer Institute, Boston, MA). Pc5-T, Pc7-T, Pc10-L, and Pc11-L
are clones of the parent EMT/6 cell line that grow as either tightly (T) or
loosely (L) adherent aggregates in three-dimensional culture, and were
described previously (St. Croix et al., 1996
 
b
 
). Stable E-cadherin–express-
ing clones of EMT/6 were obtained by lipofectin-mediated (Gibco Labo-
ratories, Grand Island, NY) cotransfection of 0.5 
 
m
 
g of the plasmid
pSV2neo along with 10 
 
m
 
g of the expression vector pBATEM2 containing
the mouse E-cadherin gene under the control of a 
 
b
 
-actin promoter (M.
Takeichi, Kyoto University, Kyoto, Japan). After selection in G418-con-
taining medium, G418-resistant clones were screened for E-cadherin
expression by immunoblotting. All EMT/6 cells were cultured in Way-
mouth’s MB 752/1 medium supplemented with 10% FBS. To prevent HA- 
St. Croix et al. 
 
p27
 
kip1
 
 Mediates E-cadherin-dependent Growth Suppression
 
559
 
mediated intercellular adhesion of Pc5-T and Pc7-T cells, 1,000 U/ml of
bovine testicular hyaluronidase (Worthington Biochemical Corp., Free-
hold, NJ) was added to three-dimensional cultures at the time of cell plat-
ing. EMT/6-E-cadherin transfectants were also grown in the presence of
hyaluronidase to ensure the absence of HA-mediated adhesion. Intercel-
lular adhesion of EMT/6-E–cadherin transfectants or E-cadherin–positive
human cell lines was prevented by treatment with 2 
 
m
 
g/ml of either anti-
E-cadherin antibody, DECMA-1 (Sigma Chemical Co., St. Louis, MO) or
SHE78-7 anti-E–cadherin antibody (Zymed Labs, Inc., S. San Francisco,
CA), respectively, at the time of cell plating. As a control, GoH3 anti-
 
a
 
6
integrin antibody (Bio/can Scientific, Mississauga, ON) was used. For anti-
bodies used in functional studies, sodium azide was removed using dialysis
cassettes (Pierce Chemical Co., Rockford, IL). Cells were collected and
assayed 48 h after treatment with hyaluronidase or E-cadherin–neutraliz-
ing antibodies, unless otherwise stated.
Human L23 large cell lung and BT-20 breast carcinoma cell lines were
maintained in RPMI 1640 containing 10% FCS. HT29 and DLD-1 colon
and MCF-7 breast carcinoma cell lines were maintained in DMEM me-
dium supplemented with 10% FCS. HBL-100 breast carcinoma cells were
grown in McCoy’s 5A medium (Gibco Laboratories) with 10% FCS. The
DLD-1 cell line was a gift from T. Sasazuki (Kyushu University, Fukuoka,
Japan) and the L23 cell line was a gift of P. Twentyman (Lincoln’s Inn
Fields, London, United Kingdom). All other cell lines were purchased
from the American Type Culture Collection (Rockville, MD). Multicellu-
lar aggregates were prepared using the liquid overlay method as previ-
ously described (Kobayashi et al., 1993). In brief, a 4% stock solution of
Seaplaque agarose (FMC Bioproducts, Rockland, Maine) was micro-
waved, diluted to 1% with heated (56
 
8
 
C) serum-free medium, and coated
(0.25 ml) into each well of 24-well plates. 10
 
5
 
 tumor cells in 1 ml of com-
plete medium were then plated on top of the solidified agarose.
 
Generation of Cell Lines with Inducible p27
 
A metallothionein-inducible p27 expression vector, pMT27, was con-
structed by excising the BglII-EcoRV fragment containing the entire hu-
man p27 cDNA from the plasmid pET-28, (a gift from L. Hengst and S.
Reed, Scripps Research Institute, La Jolla, CA), which was then ligated
between BamHI and EcoRV of the multiple cloning site of the plasmid
pCDNA3-MT. pCDNA3-MT, a gift from J. Filmus (Sunnybrook Health
Science Center, Toronto, ON), was generated by replacing the CMV pro-
moter of the plasmid pCDNA3 (Invitrogen Corp., Carlsbad, CA) with the
rat metallothionein promoter. Stable clones expressing inducible p27 were
obtained by transfecting HT29 or DLD-1 cells with 5 
 
m
 
g of pMT27 using
standard lipofectin procedures followed by selection in G418-containing
medium. G418-resistant clones were screened for inducible p27 by immu-
noblotting. For induction of the metallothionein promoter, media was
supplemented with either 1
 
3
 
 ZnCd (100 
 
m
 
M ZnSO
 
4
 
 and 2 
 
m
 
M CdCl
 
2
 
) or
2
 
3
 
 ZnCd (200 
 
m
 
M ZnSO
 
4
 
 and 4 
 
m
 
M CdCl
 
2
 
).
 
Bromodeoxyuridine (BrdU) Incorporation Assay
 
EMT/6 cells growing in either three-dimensional culture for 24 h or in
monolayer culture were pulsed with 5 
 
m
 
M BrdU for a further 24 h, after
which cells were immediately rinsed with PBS, trypsinized, rinsed again,
and fixed with 70% ethanol (4
 
8
 
C) for at least 1 h. Cells were rinsed with
PBS, pelleted, and resuspended in 1 ml of cold 0.1 N HCl/0.7% Triton X-100
and left for 10 min on ice. After rinsing once with PBS, cells were resus-
pended in 0.5 ml of distilled water and transferred into a 0.5-ml Eppendorf
tube already containing 16 
 
m
 
l of 0.1 N HCl. Next, Eppendorf tubes were
heated in a PCR machine for 8 min at 95
 
8
 
C and placed immediately on ice.
Cells were then transferred to a 5-ml tube, rinsed two times with HNFN
buffer (i.e. 10 mM Hepes [pH 7.4], 150 mM NaCl, 4% FCS, 0.1% NaN
 
3
 
)
containing 0.5% Tween 20, and once with HNFN alone. Pellets were then
resuspended in a 1/40 dilution of fluorescein isothiocyanate (FITC)-conju-
gated anti-BrdU antibody (Cedarlane Labs. Ltd., Hornby, Ontario, Can-
ada) and left in the dark on ice for 45 min. Stained cells were rinsed twice
with HNFN Tween 20, once with HNFN, pelleted, resuspended in 1 ml of
PI solution (50 
 
m
 
g/ml propidium iodide, 10 
 
m
 
g/ml RibonucleaseA in PBS),
and left for 1 h (4
 
8
 
C) in the dark before analyzing on an Epics Elite V flow
cytometer (Coulter Electronics, Burlington, Ontario, Canada).
 
[
 
3
 
H]Thymidine Incorporation Assay
 
Cells growing in monolayer culture were harvested, and 10,000 cells/well
in a final volume of 100 
 
m
 
l of medium were added to 96-well U-bottom
Nunc plates (Canadian Life Technologies, Burlington, Ontario, Canada).
To prevent attachment of cells to the bottom of 96-well plates, the wells
had been previously treated with a heated (56°C) solution of 2%
poly(2-hydroxyethylmethacrylate) (polyhema; Aldrich Chemical Co., Mil-
waukee, WI) in ethanol, which was briefly added to and then removed
from the plate, leaving behind a thin film in each well. Intercellular adhe-
sion of E-cadherin–positive human cell lines was prevented by supple-
menting wells with various concentrations of SHE78-7 anti-E-cadherin
antibody or isotype-matched control IgG antibodies (Sigma Chemical
Co.). All cells were cultured in their normal growth medium containing
10% FCS, with the following exceptions: in the experiment that examined
mitogen-dependence of growth stimulation by E-cadherin antibodies, cells
were plated in serum-free medium or medium containing either 10% FCS
or 50 ng/ml TGF-
 
a
 
 (R&D Systems, Inc., Minneapolis, MN). TGF-
 
a
 
 sig-
naling was inhibited using 20 
 
m
 
g/ml of the C225-neutralizing anti-EGFR
monoclonal antibody (ImClone, New York, NY). To analyze potential
pathways involved in TGF-
 
a
 
 signaling, E-cadherin antibody-dispersed
HT29 cells were plated in the presence of 50 ng/ml TGF-
 
a
 
 along with ei-
ther the (PI3K) inhibitor LY294002 (BIOMOL Research Laboratories,
Inc., Plymouth Meeting, PA), or the antioxidant 
 
N
 
-acetyl-
 
l
 
-cysteine
(Sigma Chemcial Co.). Cells in this experiment were labeled after 20 h of
incubation in three-dimensional culture by adding 2 
 
m
 
Ci of [
 
3
 
H]thymidine
in 50 
 
m
 
l of medium to each well. In all other experiments, labeling of cells
began at 44 h. After a 4-h pulse (i.e., at 24 or 48 h), labeled cells were fro-
zen at 
 
2
 
20
 
8
 
C. Importantly, [
 
3
 
H]thymidine has been shown to penetrate
large (400–600 
 
m
 
m) spheroids rapidly, reaching full distribution in less
than 1 min (Nederman et al., 1988). Next, cells were harvested onto filter-
mats using a Titertek cell harvester 530, and radioactive filtermats were
counted using a 1205 beta plate liquid scintillation counter (Fisher Scien-
tific Ltd., Nepean, Ontario, Canada). The rate of DNA synthesis of the
groups treated with anti-E-cadherin antibodies was calculated as a frac-
tion of the nontreated controls.
 
Immunoblotting
 
Cells were lysed in ice-cold NP-40 lysis buffer (1% NP-40, 10% glycerol,
20mM Tris-HCl [pH 7.5], 137 mM NaCl, 100 mM NaF, 1 mM sodium van-
adate, 1 mM phenylmethyl sulphonyl fluoride, and 10 
 
m
 
g/ml each of leu-
peptin and aprotinin). The lysates were sonicated and clarified by centrif-
ugation, resolved by SDS-PAGE , blotted onto Immobilon-P-membranes
(Millipore Corporation, Bedford, MA) and blocked in 10% dry milk in
TBS-T (TBS [pH 7.6], 0.1% Tween 20). mAbs to p27 and E-cadherin,
used for immunoblotting, were obtained from Transduction Laboratories
(Lexington, KY), mAb against pRb was from PharMingen (Mississauga,
Ontario, Canada), polyclonal antibody (pAb) to 
 
b
 
-catenin was from
Sigma Chemical Co.(Oakville, Ontario, Canada), pAb to 
 
a
 
-catenin was
from Zymed Laboratories, Inc. (San Francisco, CA), pAbs to cyclin E,
cdk2, cdk4, cdk6, p130, p16, p18, p19, p21, and mAb against mouse cyclin
D1 were from Santa Cruz Biotechnology (Santa Cruz, CA). DCS-6 mAb,
a gift from J. Bartek (Danish Cancer Society, Denmark) was used to detect
human cyclin D1. After washing in TBS-T, the immunoreactive proteins
were visualized using either HRP-conjugated anti-mouse- or anti-rabbit
IgG (Jackson ImmunoResearch Laboratories, West Grove, Pennsylva-
nia), and the enhanced chemiluminescence Western blotting detection
system (Amersham Canada Ltd., Oakville, Ontario).
 
Immunoprecipitation
 
Cells were lysed in NP-40 lysis buffer and immunoprecipitated with anti-
bodies to E-cadherin (Transduction Laboratories) overnight or to cyclin E
for 90 min (4
 
8
 
C). In some cases, before cyclin E immunoprecipitation, sam-
ples were divided into two separate tubes, and one was serially immuno-
depleted three times with p27 antibodies. E-cadherin and cyclin E precipi-
tates were collected for 1 h on either protein G or protein A Sepharose
beads, respectively. After washing four times with lysis buffer, precipitates
were resuspended in Laemmli SDS sample buffer and resolved by SDS-
PAGE. The immunoprecipitated protein complexes were resolved and
probed as for the immunoblots to detect associated proteins using anti-
bodies against the p27 and cyclin E primary antibodies. In the case of p27,
an HRP-conjugated anti-mouse IgG that only recognized the Fc
 
g
 
 frag-
ment (Jackson ImmunoResearch Laboratories) was used to avoid cross-
reactivity with the light chain of the immunoprecipitating antibody that
ran at a molecular weight similar to p27. Likewise, an HRP-conjugated
anti-rabbit IgG specific for the F(ab
 
9
 
)
 
2
 
 fragment (Jackson ImmunoRe-
search Laboratories) was used to avoid cross-reactivity with the heavy 
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chain of the cyclin E immunoprecipitating antibody. Because some resid-
ual heavy chain cross-reactivity was still observed, a high cross-linking gel
(7.5% acrylamide, 0.25% bis-acrylamide) was used to maximize separa-
tion of the bands.
 
Cyclin-E–dependent Kinase Assay
 
To measure cyclin E–associated cdk2 activity, cells were lysed in ice-cold
kinase lysis buffer (150 mM NaCl, 50 mM Tris [pH 7.6], 0.1% NP40, 1 mM
PMSF, 10 
 
m
 
g/ml leupeptin, 2 
 
m
 
g/ml aprotinin) and 100 
 
m
 
g of total protein
was immunoprecipitated with anti-cyclin E antibody. After washing the
precipitates three times with kinase lysis buffer and twice with reaction
buffer (22 
 
m
 
M ATP, 7.5 mM MgCl
 
2
 
,
 
 
 
and 20 mM Tris, pH 7.5), 0.25 
 
m
 
g of
Histone H1 (Boehringer Mannheim, Laval, Quebec, Canada) and 10 
 
m
 
Ci
of 
 
32
 
P-
 
g
 
 ATP were added to the reaction buffer for 30 min at 37
 
8
 
C. Reac-
tion products were resolved by SDS-PAGE, and the gel was dried and ex-
posed to x-ray film.
 
p27 Immunodepletion
 
Cells lysed in kinase lysis buffer were immunodepleted of p27 by three se-
quential 60-min immunoprecipitations using p27 polyclonal antibodies
(Santa Cruz Biotechnology). After each round of immunoprecipitation,
complexes were collected for 30 min on protein A Sepharose beads, and
were then washed extensively with lysis buffer. Beads from each round
were resuspended in Laemmli SDS sample buffer, and eluted protein was
resolved by SDS-PAGE and probed with anti-p27 antibodies by immuno-
blotting. Supernatants from the final round of immunodepletion were im-
munoprecipited with cyclin E, and cyclin E–associated proteins and kinase
activity were assayed.
 
Results
 
E-cadherin Mediates Intercellular Adhesion and 
Growth Suppression of EMT/6 cells
 
To investigate the impact of E-cadherin on contact-depen-
dent growth regulation, we transfected EMT/6 mouse
mammary carcinoma cells with a murine E-cadherin ex-
pression vector under control of a constitutive 
 
b
 
-actin pro-
moter. Neomycin-resistant control transfectants like the
EMT/6 parent cell line were loosely adherent in three-
dimensional culture (Fig. 1), and lacked any detectable
E-cadherin expression by Western blot analysis, although 
 
a
 
-
and 
 
b
 
-catenin were readily detectable in these cells (see
Fig. 2 and data not shown). In contrast, within 24 h E-cad-
herin transfectants spontaneously formed compact multi-
cellular aggregates, and expressed high levels of E-cad-
herin protein. To confirm that E-cadherin was responsible
for the increased compaction of these clones, suspension
cultures were treated with DECMA-1 antibody, which
blocks mouse E-cadherin–mediated adhesion (Vestweber
and Kemler, 1985). As shown in Fig. 1, DECMA-1 anti-
body completely prevented E-cadherin–dependent aggre-
gation, while neutralizing anti-
 
a
 
6 integrin antibody used as
a control had no effect on adhesion, even though these cells
express high levels of 
 
a
 
6
 
b
 
4 integrin (our unpublished ob-
servations). Furthermore, treatment with DECMA-1 did
not block HA-dependent aggregation of EMT/6 cells. Con-
versely, hyaluronidase abolished HA-dependent adhesion,
but failed to block E-cadherin–mediated adhesion. E-cad-
herin transfectants were also dispersed by adding EDTA;
however, such treatment did not affect cells with HA-
dependent adhesion (our unpublished observations). Thus,
using EMT/6 cells we have generated a convenient model
to study the effects of two distinct adhesion systems: one
dependent on E-cadherin and the other dependent on HA.
Our previous studies demonstrated that HA-dependent
aggregation of EMT/6 variants results in reduced prolifer-
ation of cells in three-dimensional culture (St. Croix et al.,
1996
 
b
 
). To determine if E-cadherin also suppressed cell
proliferation, we pulsed EMT/6-E-cadherin transfectants
for 24 h with bromodeoxyuridine (BrdU), stained cells
with FITC-tagged anti-BrdU antibody, and then analyzed
BrdU incorporation into DNA by flow cytometry. As
shown in Fig. 3 
 
a
 
 and Table I, 49–70% of cells from E-cad-
herin–expressing clones incorporated BrdU after a 24-h
pulse in three-dimensional culture. In contrast, under the
same conditions, over 95% of loosely adherent neomycin
control transfectants incorporated BrdU. E-cadherin–
expressing cells that failed to incorporate BrdU were found
to be primarily in the G1 phase of the cell cycle (
 
z
 
80–90%;
see Fig. 3 
 
a
 
 and data not shown). The remaining non-BrdU-
labeled cells were found in the S- and G2/M-phase, consis-
tent with other reports on cell cycle kinetics in spheroids
Figure 1. Morphology of EMT/6 cells displaying either E-cad-
herin or HA-dependent intercellular adhesion in three-dimen-
sional culture. (a–c) EMT/6 cells transfected with E-cadherin
(Ecad9); (d) with neomycin vector alone (neo8), or (e and f) Pc5-T
cells with HA-dependent adhesion were cultured with 1,000 U/ml
hyaluronidase (a–d, f), 10 mg/ml DECMA-1 antibody (c and e),
or 10 mg/ml of GoH3 anti-a6-integrin antibody (b). Cells were
photographed after 24 h in three-dimensional culture. Bar, 50 mm. 
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(Allison et al., 1983; Freyer and Sutherland, 1980). It is un-
likely that an insufficient BrdU pulse is responsible for
nonlabeled S- and G2/M-phase cells, because the BrdU-
labeling time chosen (24 h) exceeded the cell division time
(
 
z
 
16 h; our unpublished observations). An independent
pulse labeling with [
 
3
 
H]thymidine over 4 h confirmed the
BrdU results, and demonstrated that treatment of EMT/6-
E-cadherin transfectants with 2 mg/ml DECMA-1 neutral-
izing antibody restored [3H]thymidine uptake to the level
observed in neomycin-resistant control transfectants (see
Fig. 3 b). Importantly, the observed growth inhibition me-
diated by E-cadherin in three-dimensional cultures was
not detected in subconfluent monolayer cultures (see Ta-
ble I). Likewise 2 mg/ml DECMA-1 antibody had no effect
on growth of subconfluent monolayers, and a very minor
effect, if any, on confluent cultures (data not shown).
Growth Suppression by E-cadherin is Associated
with pRb Hypophosphorylation, Reduced Cyclin D1,
and Elevated p27 Levels in EMT/6 Cells
To elucidate the mechanism responsible for E-cadherin–
dependent growth suppression, an analysis of cell cycle
regulators was undertaken. As a control, we included an
analysis of EMT/6 variants that display either a loosely ad-
herent or HA-dependent tightly adherent morphology in
three-dimensional culture. Since the majority of noncy-
cling tightly adherent cells were found to be in the G1
phase of the cell cycle (Fig. 3 a), Western blots were
probed for cell cycle regulators of G1®S-phase progres-
sion. The pRb protein was almost exclusively hyperphos-
phorylated in all EMT/6 loosely adherent cell types (Fig.
4  a), including neomycin-resistant control transfectants
(neo1 and neo4), DECMA-1–treated E-cadherin transfec-
tants (Ecad3, Ecad7, and Ecad9), loosely adherent clones
(Pc10-L and Pc11-L), and two tightly adherent clones
(Pc5-T and Pc7-T) that had been dispersed with hyal-
uronidase. In contrast, the hypophosphorylated faster-
migrating form of pRb was prominent only in tightly
adherent variants displaying either E-cadherin or HA-depen-
dent adhesion. Hypophosphorylation of the pocket pro-
tein p130 was also noted in tightly adherent clones (data
not shown). For both pRb and p130, changes in phosphor-
ylation status were only evident in cells grown in three-
dimensional culture.
Next we analyzed the expression of cell cycle molecules
of potential importance in mediating the E-cadherin–depen-
dent growth suppression and the changes in pRb and p130
phosphorylation. After 48 h in three-dimensional culture,
levels of cdk2, cdk4, and cdk6 were unchanged in all EMT/6
cells regardless of their capacity to aggregate. Likewise,
cyclin E and A protein levels were unaffected by the de-
gree of intercellular adhesion (Fig. 4 a and data not
shown). In contrast, after 48 h in three-dimensional cul-
ture, levels of cyclin D1 were consistently higher in EMT/6
cells growing in loosely adherent clusters, as compared
with tightly adherent cells. In monolayer culture, levels of
cyclin D1 were unaffected 48 h after treatment with
DECMA-1 or hyaluronidase (data not shown).
We also analyzed levels of known CKIs. Although p15
was not detected in EMT/6 cells, p16, p18, p19, and p21
were expressed, but levels of these inhibitors did not cor-
relate with adhesion. (Fig. 4 a and data not shown). We
were particularly interested in the effect of E-cadherin on
p27 protein levels since previous studies have implicated
this CKI in contact-dependent growth inhibition (Slinger-
land et al., 1994; Hengst et al., 1994; Polyak et al., 1994; St.
Croix et al., 1996a). Although the base level of p27 varied
somewhat between individual clones, cell lines with a
tightly adherent morphology generally displayed higher
p27 levels than did loosely adherent variants (see Fig. 4 a).
Furthermore, high p27 levels in tightly adherent clones
displaying either E-cadherin or HA-dependent adhesion
were consistently reduced by treatment with either
DECMA-1 or hyaluronidase, respectively. In contrast, this
treatment did not affect loosely adherent control cells
grown under the same conditions, or tightly adherent cells
grown in monolayer (data not shown). Thus, increased p27
levels paralleled aggregate compaction, and an inverse
pattern was observed for cyclin D1, but only in three-dimen-
sional culture.
To determine the kinetics of changes in p27 and cyclin
D1 in response to aggregation, levels of these proteins
were assayed at various time points after plating cells into
three-dimensional culture. As shown in Fig. 4 b, within 6 h
of transferring cells to three-dimensional culture, p27 lev-
els were increased in E-cadherin–expressing cells. The de-
crease in cyclin D1, however, occurred between 24 and 48 h,
and its levels fell progressively thereafter. There was no in-
crease in the association of p27 with cyclin D1 after trans-
fer of E-cadherin–overexpressing clones into three-dimen-
sional culture (data not shown). Thus, our data do not
support a role for p27 as an inhibitor of cyclin D1-associ-
ated cdk activity after growth suppression by E-cadherin.
Figure 2. Immunoblot analysis of E-cadherin and b-catenin in
EMT/6 cells. EMT/6 neomycin-resistant control transfectants
(neo1, neo4), E-cadherin transfectants (Ecad3, Ecad7, or Ecad9),
or EMT/6 loosely adherent (Pc10-L and Pc11-L) or tightly adher-
ent (Pc5-T, PcT-7) variants were grown for 48 h in three-dimen-
sional culture. E-cadherin–dependent adhesion was prevented by
treatment with DECMA-1 antibody (Dec), and HA-dependent
adhesion was prevented with hyaluronidase (Hy). In the top
panel, anti-E-cadherin and anti-b-catenin antibodies detected
proteins of 120 and 95 kD, respectively, by Western blot analysis.
When cell lysates were immunoprecipitated with E-cadherin anti-
bodies and then immunoblotted with anti-E-cadherin and anti-
b-catenin antibodies (bottom), again bands of 120 and 95 kD
were detected.The Journal of Cell Biology, Volume 142, 1998 562
Because p27 upregulation by cell–cell contact occurred
rapidly, and this CKI has been shown to inhibit cyclin E-cdk2
(Slingerland et al., 1994; Hengst et al., 1994; Polyak et al.,
1994), we analyzed cyclin E–associated cdk2 activity. Cy-
clin E-cdk2 activity was reduced in E-cadherin transfec-
tants compared with neomycin resistant controls (see Fig.
5 a). Likewise, tightly adherent Pc5-T cells displayed low
cyclin E–associated kinase activity in three-dimensional
culture. Kinase activity was increased when hyaluronidase
was added to the medium, or when cells were grown in
monolayer culture. Immunoprecipitation blotting revealed
higher levels of p27 bound to cyclin E in tightly adherent
spheroids compared with their loosely adherent counter-
parts (see Fig. 5 b), while cyclin E levels were unchanged
(not shown). To demonstrate that increased p27 binding
was responsible for the decreased cyclin E–associated ki-
nase activity, we immunodepleted p27 from cadherin-
arrested cells (Fig. 5 c). As shown in Fig. 5 d, almost all of
Figure 3. E-cadherin suppresses growth of EMT/6 cells in three-dimensional culture. (a) Proliferation of EMT/6 cells transfected with
E-cadherin (Ecad9) or neomycin vector alone (neo1) as measured by BrdU incorporation into DNA. 24 h after plating in three-dimen-
sional culture, cells were either untreated (2BrdU) or pulsed with BrdU (1BrdU) for a further 24 h. Cells were prepared as described
in the Materials and Methods, and cell cycle profiles were analyzed by flow cytometry. Tightly adherent or hyaluronidase (HYase) dis-
persed Pc5-T cells were also included as an additional control. (b) Proliferation of neomycin-resistant control transfectants (neo4, neo7,
neo8) or E-cadherin transfectants (Ecad3, Ecad7, Ecad9, and Ecad18) as measured by [3H]thymidine incorporation into DNA. Intercel-
lular adhesion of E-cadherin transfectants was prevented by treatment with 2 mg/ml DECMA-1 antibody at the time of plating.
Table I. Ability of Cells to Aggregate in Three-dimensional Culture Correlates with Fraction of Proliferating EMT/6 Cells 
According to Percentage of BrdU-labeled Cells After a 24-h Pulse
neo1 neo4 neo7 neo8 Ecad3 Ecad7 Ecad9 Ecad18 Pc10-L Pc5-T Pc5-T 1HYasei
Aggregates* 2222 1 1 1 1 2 1 2
2-D‡ 99.2 99.7 99.9 99.9 99.8 99.9 99.8 99.5 99.7 99.2 99.2
3-D§ 98.1 97.1 95.1 96.7 49.8 53.8 59.9 70.3 97.1 53.5 95.8
*Ability of cells to form aggregates in three-dimensional culture. (2) indicates loosely or nonadherent aggregates, and (1) indicates tightly adherent aggregates as shown in Fig.
1. ‡Two-dimensional monolayer culture. §Three-dimensional culture. iHyaluronidase-treated.St. Croix et al. p27kip1 Mediates E-cadherin-dependent Growth Suppression 563
the detectable cyclin E was removed from the cell lysate
by serial immunodepletion of p27. After p27 immunode-
pletion, the minor amount of residual free cyclin E-cdk2
remaining in the supernatant had a dramatically elevated
kinase activity (Fig. 5 e). This increase in kinase activity
may occur because p27 is no longer available to block cy-
clin E-cdk2 activity directly or indirectly through a release
of the steric inhibition of CAK phosphorylation imposed
by p27 (Mandal et al., 1998; Kato et al., 1994). Taken to-
gether, these studies suggest that the inhibition of cyclin
E-cdk2 by E-cadherin is mediated by p27.
E-Cadherin–neutralizing Antibodies Fail to Release
b-Catenin from E-Cadherin
The mechanism by which E-cadherin regulates p27 is un-
clear. Because b-catenin has been implicated in signal
transduction (Behrens et al., 1996; Molenaar et al., 1996;
Huber et al., 1996), we investigated whether DECMA-1
induces growth of E-cadherin transfectants by stimulating
the release of b-catenin bound to E-cadherin at the cell
surface. As shown in Fig. 2, levels of endogenous b-catenin
protein were elevated in all EMT/6-E-cadherin transfec-
tants, an observation consistent with other reports (Pap-
koff, 1997); this is most likely due to stabilization of
b-catenin bound to E-cadherin at the cell surface. b-cate-
nin levels in E-cadherin immunocomplexes were unaf-
fected by DECMA-1 antibody treatment (see Fig. 2).
Likewise, levels of E-cadherin bound to immunoprecipi-
tated b-catenin were unchanged by this antibody treat-
ment (data not shown). These results suggest that changes
in the association of b-catenin with E-cadherin are not in-
volved in growth stimulation mediated by E-cadherin–
neutralizing antibodies.
Endogenous E-Cadherin Mediates Intercellular 
Adhesion, Growth Suppression, and Upregulation of 
p27 in Human Carcinoma Cell Lines
To ascertain the role of E-cadherin in contact-dependent
growth inhibition, we analyzed the effect of SHE78-7, an
anti-human E-cadherin–neutralizing antibody (Watabe et
al., 1994), on various human E-cadherin positive colon
(HT29 and DLD-1), breast (MCF-7 and BT-20), and lung
(L23) carcinoma cell lines. Similar to our observations with
EMT/6-E-cadherin transfectants, SHE78-7 antibody was
highly effective at preventing E-cadherin–mediated adhe-
sion (Fig. 6 and data not shown). In contrast, intercellular
adhesion of these human cells was unaffected by isotype-
matched control IgG, and SHE78-7 failed to block adhesion
of tightly adherent HBL-100 breast carcinoma cells that lack
any detectable E-cadherin expression (see Figs. 6 and 8).
We next asked whether blocking E-cadherin function
could stimulate the growth of these human cell lines. As
shown in Fig. 7, adding SHE78-7 to the culture medium
caused a dose-dependent increase in [3H]thymidine up-
take by each of the colon, breast, and lung cancer cell lines
tested. The effect of SHE78-7 on growth paralleled its ef-
fect on intercellular adhesion. Interestingly, antibody stim-
ulation reached a plateau at concentrations of 1–2 mg/ml,
presumably due to saturation of antibody-binding sites at
the cell surface. The antibody was completely nontoxic,
even at concentrations of 50 mg/ml (data not shown).
Again, E-cadherin–negative HBL-100 cells were unaf-
fected by SHE78-7.
Figure 4. Changes in cell cycle molecules in response to intercel-
lular adhesion of EMT/6 cells as detected by immunoblotting. (a)
Three-dimensional cultures of EMT/6 neomycin–resistant con-
trol transfectants (neo1, neo4), E-cadherin transfectants (Ecad3,
Ecad7, and Ecad9), EMT/6 loosely-adherent variants (Pc10-L
and Pc11-L) or HA-dependent tightly adherent variants (Pc5-T,
PcT-7) were examined. Immunoblots were probed for the cell cy-
cle molecules indicated. E-cadherin- or HA-dependent intercel-
lular adhesion was prevented by treatment with either DECMA-1
antibody (Dec) or hyaluronidase (Hy), respectively. Note
changes in pRb phosphorylation and levels of cyclin D1 and p27
in cells allowed to aggregate in three-dimensional culture. (b)
Time course demonstrating changes in p27 and cyclin D1 protein
levels as cells aggregate in three-dimensional culture. Cells trans-
fected with E-cadherin (Ecad3) grown in the presence or absence
of 2 mg/ml DECMA-1 antibody for the indicated times were
probed for p27 and cyclin D1 by immunoblotting. At time 5 0
cells were transferred from two- to three-dimensional culture.The Journal of Cell Biology, Volume 142, 1998 564
To determine whether the effects of E-cadherin on pRb,
p130, cyclin D1, and p27 in murine EMT/6 cells were simi-
lar in human cells, we analyzed levels of these proteins in
colon (HT29 and DLD-1), lung (L23), and breast (BT20
and HBL100) carcinoma cell lines. Cells grown for 48 h in
three-dimensional culture in either the presence or ab-
sence of SHE78-7 antibody were analyzed by Western blot
analysis. Similar to our previous results with EMT/6-E-
cadherin transfectants, when E-cadherin–mediated adhe-
sion of human cells was abrogated by SHE78-7, there was
a shift to increased phosphorylation of pRb and p130 (see
Fig. 8). However, unlike in our initial experiments, adding
E-cadherin–neutralizing antibodies did not result in a de-
tectable increase in cyclin D1 by 48 h. In each of the E-cad-
herin–positive cell lines allowed to aggregate, p27 levels
increased from z2.5-fold to z15-fold depending on the
cell line, and this effect could be reversed by SHE78-7 an-
tibody. Importantly, E-cadherin–negative HBL100 cells
were unaffected by E-cadherin antibody treatment.
Enforced Upregulation of p27 Inhibits the Proliferation
Induced by Anti-E-Cadherin Antibodies
To assess further the role of p27 in E-cadherin–mediated
growth suppression, we transfected HT29 cells with a metal-
lothionein-inducible human p27 expression vector. One of
the transfectants, H/MT27, which was found to produce
high levels of p27 in response to treatment with zinc and
cadmium, was plated into three-dimensional culture in the
presence or absence of SHE78-7 E-cadherin–neutralizing
antibody. Importantly, by titrating the concentration of
zinc and cadmium, we were able to control the level of p27
in these cells accurately. Thus, in HT29 cells in which in-
tercellular adhesion was prevented by SHE78-7 antibody
treatment, we could enforce expression of the same
amount of p27 that was present in tightly adherent cells
grown in the absence of SHE78-7. As shown in Fig. 9, en-
forced elevation of p27 in SHE78-7–treated cells inhibited
by z50% the increase in proliferation mediated by block-
ing E-cadherin with SHE78-7. In contrast, neither the
HT29 parent population or neomycin-resistant control
transfectants were significantly affected by treatment with
zinc and cadmium. We have observed similar results for
pMT27 transfectants of DLD-1 cells (data not shown).
Figure 5. Increased p27 binding to cyclin E mediates reduced Cyclin
E–associated kinase activity in aggregated cells. (a) Cyclin E–asso-
ciated cdk2 kinase activity, as measured by phosphorylation of
Histone H1 substrate in representative neomycin-resistant con-
trol transfectants (neo1, neo4, neo8) or E-cadherin transfectants
(Ecad1, Ecad9, Ecad18) grown in three-dimensional culture.
Also included are Pc5-T cells grown in monolayer (2-D) culture,
or in three-dimensional culture in either the presence or absence
of hyaluronidase (Hy). (b) Increased levels of p27 bound to cyclin
E in tightly adherent EMT/6 spheroids. After immunoprecipitat-
ing cyclin E from tightly- or loosely adherent aggregates, levels of
cyclin E–bound p27 were detected by immunoblotting. Cell-free
lysis buffer was used for the control sample. (c) Immunodepletion
of p27 from aggregated E-cadherin transfectants. Cell extracts im-
munodepleted one (13) or two (23) times with antibodies against
p27 were probed for p27 by immunoblotting. Controls (Con)
represent extracts before immunodepletion (d). Cyclin E, cyclin
E–associated cdk2, and p27 are markedly reduced in p27-immu-
nodepleted (ID) supernatents from E-cadherin–aggregated cells.
Cyclin E immunoprecipitates from lysates with or without prior
immunodepletion with p27 antibodies were probed for cyclin E,
cdk2, or p27 by immunoblotting. As a control, Ecad9 lysates were
immunoprecipitated with nonspecific rabbit IgG antibodies in-
stead of cyclin E antibodies. (e) Cyclin E–associated cdk2 kinase
activity is increased after p27-immunodepletion (ID) of E-cad-
herin–arrested cells. The representative control in this experiment
was Ecad7 lysate immunoprecipitated with nonspecific rabbit IgG
antibodies instead of cyclin E antibodies. In each of these experi-
ments cells were cultured for 48 h in three-dimensional culture.St. Croix et al. p27kip1 Mediates E-cadherin-dependent Growth Suppression 565
These results suggest that p27 levels are rate-limiting for
the growth of cells that are loosely adherent, and support
the conclusion that increased p27 levels mediate E-cad-
herin–dependent growth inhibition.
E-Cadherin Suppresses Growth by Inhibiting 
Downregulation of p27 by Growth Factors
Recent studies have provided circumstantial evidence that
E-cadherin–mediated adhesion may suppress growth by
inactivating RTK activity. Before testing this directly, we
asked whether or not E-cadherin–neutralizing antibodies
could stimulate growth in the absence of mitogens in the
culture medium. HT29 was used since this cell line is E-cad-
herin–positive and continues to grow, albeit more slowly,
in the absence of FCS (see Fig. 10 a). When HT29 cells
were treated with SHE78-7 in serum-free medium, p27
levels remained high, and [3H]thymidine uptake was unaf-
fected, even though intercellular adhesion was prevented.
When 10% FCS was added to the medium alone, only a
twofold increase in [3H]thymidine uptake of compact ag-
gregates was observed. Adding 50 ng/ml TGF-a was mod-
erately more potent, causing an z threefold stimulation of
[3H]-thymidine uptake. These were optimal growth stimu-
latory concentrations of FCS and TGF-a in three-dimen-
sional culture as determined by dose-response studies
(data not shown). However, if E-cadherin–mediated adhe-
sion was blocked by SHE78-7, growth stimulation by FCS
Figure 6. Morphology of human E-cadherin–positive cell lines in
three-dimensional culture. E-cadherin positive HT29 colon (a and
b), L23 lung (c and d), BT20 breast (e and f), or E-cadherin–nega-
tive HBL100 breast carcinoma cell lines (g and h) were cultured in
the presence of 2 mg/ml SHE78-7 anti-E-cadherin antibody (b, d,
f, and h) or isotype-matched control IgG antibody (a, c, e, and g).
Cells were photographed 24 h after plating. Bar, 50 mm.
Figure 7. E-cadherin–neutralizing antibodies stimulate the growth
of human E-cadherin positive cell lines in three-dimensional cul-
ture. Colon (HT29, DLD-1), lung (L23), and breast (BT20,
MCF-7,  HBL100) carcinoma cell lines were cultured for 48 h in
the presence of SHE78-7 anti-E-cadherin antibodies (d) or iso-
type-matched control IgG antibodies (m). After pulsing with
[3H]thymidine, radioactivity incorporated into DNA was mea-
sured and expressed as a percentage of nontreated control cells.
Note that E-cadherin antibodies only stimulate the growth of cell
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was even greater (z fivefold), while TGF-a stimulated
growth almost tenfold compared with serum-free controls.
These effects on [3H]thymidine uptake were clearly syner-
gistic because SHE78-7 antibody had no effect on prolifer-
ation by itself in the absence of mitogens. When TGF-a,
FCS, and SHE78-7 were all added simultaneously, an even
larger (z14-fold) growth stimulation was noted (data not
shown). Importantly, the growth stimulation observed
after treatment with E-cadherin antibodies was associated
with a reduction in p27 protein. Furthermore, the ability of
TGF-a to both stimulate growth and reduce p27 protein
levels could be completely abrogated by adding C225
EGFR-blocking antibody to the culture medium. In con-
trast, treatment with C225 had no effect on FCS-induced
growth stimulation. We conclude that E-cadherin inhibits
growth of HT29 cells by inhibiting either TGF-a stimula-
tion of EGFR kinase activity or serum stimulation of an
uncharacterized mitogenic pathway.
One mechanism by which cell–cell adhesion may pre-
vent kinase activity of growth factor receptors is by stimu-
lating endogenous phosphatase activity. To determine if
such a mechanism could be responsible for elevated p27
protein levels in aggregated HT29 cells, we treated these
cells with the phosphatase inhibitor sodium orthovandate.
As shown in Fig. 10 b, vanadate treatment resulted in low
p27 protein levels in adherent spheroids. Thus, endoge-
nous phosphatase activity is necessary for p27 upregula-
tion in compact spheroids.
Intracellular Signaling Events Involved in Regulation of 
p27 Protein Levels
PI3K is activated by a number of growth factors including
EGF, and is a direct downstream target of ras (Bjorge et al.,
1990; Rodriguez-Viciana et al., 1994). To test whether
PI3K signaling plays a role in downregulating p27 levels
and stimulating proliferation of HT29 cells dispersed with
SHE78-7 antibody, we treated these cells with LY294002,
Figure 8. Changes in cell cycle regulators in response to E-cad-
herin–mediated adhesion of human carcinoma cell lines. Immu-
noblots of colon (HT29, DLD-1), lung (L23), and breast (BT20)
carcinoma cell lines were probed for p27, pRb, p130, and cyclin
D1. E-cadherin–dependent intercellular adhesion was prevented
by treatment with 2 mg/ml of SHE78-7 antibody (1SHE).
Figure 9. Enforced expression of
p27 inhibits cell growth in the
presence of E-cadherin neutraliz-
ing antibodies. HT29 cells trans-
fected with a metallothionein-
inducible p27 expression plasmid
(H/MT27), neomycin vector
alone (H/neo), or nontransfected
HT29 cells (HT29) were grown
in three-dimensional culture for
48 h in the absence (Control) or
presence of SHE78-7 antibody
(1SHE). For induction of the
metallothionein promoter, cul-
tures were supplemented with
either a one (13) or two times
(23) concentration of Zinc and
Cadmium (ZnCd). After pulsing
with [3H]thymidine, radioactivity incorporated into DNA was
measured and expressed as fold increase in counts over non-
treated control cells. The corresponding levels of p27 as deter-
mined by immunoblotting are shown in the inset.
Figure 10. E-cadherin inhibits
growth factor–mediated down-
regulation of p27 through a phos-
phatase-dependent mechanism.
(a) Mitogens are required for
growth stimulation in the pres-
ence of E-cadherin–neutralizing
antibodies. Nontreated HT29
cells (control) were grown in
serum-free medium for 48 h.
Treated cells were grown in the
presence of 2 mg/ml SHE78-7 an-
tibody (1SHE), 10% FCS
(1FCS), or 50 ng/ml TGF-a
(1TGF-a), either alone or in
various combinations. To pre-
vent TGF-a activity, cultures
were treated with c225-neutraliz-
ing anti-EGRF antibody. All fac-
tors were added to three-dimen-
sional cell cultures at the time of
cell plating. After pulsing with
[3H]thymidine, radioactivity in-
corporated into DNA was mea-
sured and expressed as fold in-
crease in counts over nontreated
control cells. The corresponding levels of p27 as determined by im-
munoblotting are shown in the inset. (b) Inhibition of phosphatase
activity lowers p27 levels in aggregated HT29 cells. HT29 cells
plated in three-dimensional culture in the presence of either FCS
or TGF-a were treated with 50 mM sodium orthovanadate
(1Van). 48 h later, cells were collected and levels of p27 were de-
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a potent inhibitor of PI3-K. As shown in Fig. 11, treatment
with LY294002 inhibited growth and increased p27 levels
in these loosely adherent E-cadherin antibody-treated
cells. A similar dose-dependent growth-inhibition was ob-
served when these cells were treated with the antioxidant
N-acetyl-l-cysteine (NAC). The effects of LY294002 and
NAC on proliferation and p27 levels did not result from
cytotoxicity, as both were reversed upon drug removal.
Importantly, both PI3K and reactive oxygen species are
thought to function in signaling pathways that operate
downstream of ras, and that are separate from the raf/
MAP kinase pathway (Rodriguez-Viciana et al., 1997;
Irani et al., 1997). In agreement with this, the MEK inhibi-
tor PD98059 did not affect growth and p27 levels in HT29
cells (data not shown).
Discussion
It has long been recognized that nontransformed cell lines
are contact-inhibited when they reach confluence in
monolayer tissue culture. However, only recently has it
been shown using normal fibroblasts and epithelial cells
that intercellular adhesion molecules such as NCAM and
E-cadherin, respectively, are involved in this process
(Aoki et al., 1991; Takahashi and Suzuki, 1996;
Kandikonda et al., 1996). Although loss of contact inhibi-
tion is one of the classical hallmarks of transformation,
many tumor cell lines also appear to maintain a degree of
contact inhibition that we refer to as contact-dependent
growth inhibition/suppression. This phenomenon, which
appears to be most pronounced when cells are cultured as
three-dimensional masses, may reflect an incomplete loss
of contact inhibition during the transformation process.
E-Cadherin Mediates Contact-dependent Growth 
Inhibition of Tumor Cells
The present study suggests that, as for normal cells, E-cad-
herin is also involved in contact-dependent growth inhibi-
tion of carcinoma cell lines that maintain functional E-cad-
herin. This was shown using E-cadherin–neutralizing
antibodies that simultaneously disrupted adhesion and
stimulated proliferation of several E-cadherin–positive
breast, colon, and lung carcinoma cell lines grown in three-
dimensional culture. Similar effects of E-cadherin on pro-
liferation were obtained by Watabe and coworkers, in this
case using an a-catenin–expressing variant of the F9 small
cell lung carcinoma cell line that has an intact E-cadherin
adhesion system (Watabe et al., 1994). Interestingly, this
cell line displays very weak attachment to tissue culture
flasks, growing mostly as free-floating multicellular spher-
oids. Furthermore, transfection of E-cadherin into carci-
noma cell lines that have lost E-cadherin expression has
been shown to cause morphological reversion to an adher-
ent epithelial phenotype, and to decrease tumor growth
rate when the cells are injected subcutaneously into mice
(Miyaki et al., 1995; Navarro et al., 1991). Similar results
were obtained after transfection of wild-type a-catenin
into an ovarian cell line with a mutant a-catenin gene
(Bullions et al., 1997). Herminston and Gordon have
shown that inactivation of endogenous E-cadherin in in-
testinal crypt cells using a dominant negative strategy
leads to the formation of adenomas (Hermiston and Gor-
don, 1995b). Conversely, forced overexpression of E-cad-
herin suppresses proliferation in the crypt (Hermiston et al.,
1996). These studies, in addition to our own, provide
strong evidence that E-cadherin is not only a suppressor of
invasion (Vleminckx et al., 1991), but also has the ability
to suppress proliferation. Importantly, E-cadherin–depen-
dent growth suppression appears to be undetectable in
subconfluent monolayer culture, but can be observed in
confluent monolayers or three-dimensional cell cultures.
Increased Levels of p27 are Involved in
E-Cadherin–mediated Growth Suppression
To elucidate the mechanism(s) responsible for E-cad-
herin–dependent growth suppression, we have investi-
gated the effect of E-cadherin–mediated adhesion on cell
cycle regulators. Our analysis revealed that the CDK in-
hibitor p27kip1 was consistently elevated in a panel of cell
lines that manifest E-cadherin–dependent adhesion com-
pared with the same cell lines rendered loosely adherent
by treatment with anti-E-cadherin antibodies. Further
studies demonstrated that this increase in p27 is responsi-
ble, at least in part, for E-cadherin–dependent growth sup-
pression through cyclin E-cdk2 inhibition. The E-cad-
herin–dependent increase in p27 was sufficient to saturate
almost all cellular cyclin E-cdk2. Very little cyclin E was
detectable after immunodepletion of p27 from E-cad-
herin–expressing clones, and loss of associated p27 led to a
dramatic increase in the activity of residual cyclin E-cdk2
complexes remaining after p27-depletion. Thus, E-cad-
herin– mediated adhesion lead to suppression of cyclin
E–associated kinase activity through increased p27 bind-
ing to the cyclinE–cdk2 complex. Furthermore, when cell
spheroids disrupted by E-cadherin–neutralizing antibodies
Figure 11. Inhibiting PI3K activity or generating reactive oxygen
species elevates p27 protein levels and reduces [3H]thymidine up-
take of E-cadherin antibody-dispersed HT29 cells. Cells plated
into three-dimensional cuture in the presence of TGF-a and
SHE78-7 antibody were treated with either (a) the PI3K inhibitor
LY294002 (LY) or (b) the antioxidant N-acetyl-l-cysteine (NAC).
[3H]thymidine incorporation was measured after 24 h. The inset
for both a and b shows the corresponding levels of p27 protein as
determined by immunoblotting.The Journal of Cell Biology, Volume 142, 1998 568
were engineered to express p27 levels corresponding to
those observed in adherent spheroids, antibody-stimulated
proliferation was repressed by z50%. Consistent with our
results, when p27 activity was first identified it was found
to mediate cyclin E–cdk2 inhibition in contact-inhibited
monolayer cultures of MvLu epithelial cells (Slingerland
et al., 1994; Polyak et al., 1994). Interestingly, MvLu cells
express E-cadherin at sites of cell–cell contact (Brady-Kal-
nay et al., 1993). We have previously shown that p27 is an
essential mediator of growth arrest in response to HA-
dependent aggregation (St. Croix et al., 1996a). We con-
clude, therefore, that p27 plays an important role in both
E-cadherin and HA-dependent growth arrest. Thus, dis-
tinct adhesion mechanisms may ultimately impinge on the
same signal transduction pathways regulating the cell cycle
machinery.
Enforced p27 overexpression in HT29 cells could only
inhibit incompletely the proliferative effect of anti-E cad-
herin antibody treatment. Thus, other factors are likely to
regulate E-cadherin-dependent growth inhibition. When
E-cadherin–positive cell lines were allowed to aggregate,
we also observed hypophosphorylation of pRb and p130,
and in tightly adherent EMT/6 cells, cyclin D1 was re-
duced. The loss of pRb and p130 phosphorylation in ad-
herent cells is most likely a consequence of reduced cy-
clin–cdk activity as cells arrest in G1/G0. However, the
E-cadherin–dependent downregulation of cyclin D1 that
occurs after cells have left the cell cycle may contribute to
maintenance of the arrested state. Effects of adhesion on
cyclin D1 appear to be cell type–dependent because, in
our panel of E-cadherin–positive human tumor lines, cy-
clin D1 levels appeared unaffected by treatment with E-cad-
herin–neutralizing antibodies. It is possible, however, that
other D-type cyclins are involved. In the EMT/6 cells,
E-cadherin may affect cyclin D1 turnover through ubi-
quitin-mediated proteolysis (Diehl et al., 1997). While fur-
ther studies are necessary to address these possibilities, a
connection between cyclin D and E-cadherin is intriguing
given the relationship between growth factor dependence
of E-cadherin–mediated growth suppression and the
known ability of growth factors to regulate cyclin D turn-
over (Sherr, 1995).
Mitogenic Pathways are Required for
E-Cadherin–dependent Growth Suppression and
Elevation of p27 Protein Levels
During the course of these studies, we became interested
in understanding signal transduction pathway(s) by which
E-cadherin regulates p27. Initially we hypothesized that
E-cadherin may sequester b-catenin at the cell surface,
thereby preventing its ability to translocate to the nucleus
and alter transcription of growth-promoting genes. How-
ever, in preliminary experiments we could find no evi-
dence to support this hypothesis, and our later results sug-
gested that classical mitogenic pathways are necessary for
growth stimulation in the presence of E-cadherin–neutral-
izing antibodies. Indeed, under serum-free conditions,
E-cadherin–neutralizing antibodies were unable to stimu-
late growth or reduce p27 levels in HT29 cells, even though
intercellular adhesion was completely prevented. How-
ever, E-cadherin–neutralizing antibodies synergized with
FCS or TGF-a, increasing their capacity to stimulate
growth of HT29 cells by 2.5- and 3.2-fold, respectively. Im-
portantly, the effect of TGF-a on both p27 levels and
growth could be completely abolished by adding C225-
neutralizing antibody against the EGFR to cell cultures.
Thus, E-cadherin–dependent adhesion regulates p27 lev-
els and proliferation indirectly by preventing the mitoge-
nic activity of soluble growth factors.
It is unclear exactly how adhesion mediated by E-cad-
herin prevents signaling through RTKs such as the EGFR,
which in turn leads to increased levels of p27 protein. Sev-
eral reports have shown that ligand-induced phosphoryla-
tion of RTKs such as the EGFR or Erb-B2 is lost upon
cell–cell contact, even in the presence of excess ligand
(Mansbridge et al., 1992; Lichtner and Schirrmacher,
1990). In one study, E-cadherin antibodies were shown to
prevent contact inhibition and restore EGFR phosphory-
lation in response to EGF (Takahashi and Suzuki, 1996).
Because phosphorylation of RTKs can be rescued upon
cell–cell contact by adding phosphatase inhibitors (Mans-
bridge et al., 1992; Sorby and Ostman, 1996), contact-depen-
dent RTK inactivation is thought to be a consequence of
endogenous phosphatase activity. Indeed, several receptor
protein tyrosine phosphatases (RPTPs) that span the cellular
membrane have been shown to be upregulated and acti-
vated by cell–cell contact (Pallen and Tong, 1991; Ostman
et al., 1994; Gebbink et al., 1995; Gaits et al., 1995) and in
some cases colocalize with cadherin–catenin complexes
(Wang et al., 1996; Kypta et al., 1996; Balsamo et al.,
1996). Tight adhesion mediated by E-cadherin or other ad-
hesion mechanisms may serve to strengthen interactions
between adjacent RPTPs, ensuring high continuous phos-
phatase activity. This in turn may lead to dephosphoryla-
tion of the EGFR, and a buildup of p27 levels (St. Croix
and Kerbel, 1997). In support of this model, we found that
the phosphatase inhibitor orthovanadate suppresses p27
induction in aggregating EMT6/E-cadherin transfectants.
Interestingly, b-catenin has been found by coimmuno-
precipitation studies to link cadherin–catenin complexes
to several receptor tyrosine kinases such as the EGFR,
c-erbB2, and possibly c-met (Hoschuetzky et al., 1994; Shi-
bata et al., 1996; Kanai et al., 1995). Whether or not adhe-
sion mediated by E-cadherin can inhibit RTK activity
through such an interaction is unclear. However, in at least
some systems the opposite appears to be true, that is,
ligand-induced activation of RTKs appears to destabilize
adhesion (Shibamoto et al., 1994; Shiozaki et al., 1995). It
has been proposed that this effect may be due to the phos-
phorylation of b-catenin by RTKs since phosphorylated
b-catenin is not found in cadherin–catenin complexes
bound to the actin cytoskeleton (Hoschuetzky et al., 1994).
Although plausible, evidence for this hypothesis is mostly
circumstantial, and one study demonstrated that phosphor-
ylation of b-catenin is not required to shift cadherin-based
adhesion from the strong to the weak state (Takeda et al.,
1995). Furthermore, we and others have found that adhe-
sion is unaffected by the presence of mitogens such as
TGF-a and EGF, arguing against a role for RTK-induced
destabilization of adhesion (Shibamoto et al., 1994). In-
stead, it has been proposed using sparse monolayer cul-
tures of normal epithelial cells that RTK phosphorylation
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thereby preventing an inappropriate connection to the un-
derlying cytoskeleton before cell–cell contact occurs (Ta-
kahashi and Suzuki, 1996). Once cell–cell contact occurs,
dephosphorylation of RTKs by phosphatases may effec-
tively block b-catenin phosphorylation.
The mechanisms by which mitogen-activated RTK sig-
naling pathways regulate p27 is an area of active investiga-
tion. Several studies have demonstrated that p27 levels are
reduced in epithelial cells, endothelial cells, fibroblasts,
and T-cells in response to growth factors such as EGF,
VEGF, PDGF, and IL2 (Sandhu et al., 1997; Peng et al.,
1996; Watanabe et al., 1997; Agrawal et al., 1996; Shank-
land et al., 1997; Winston et al., 1996; Coats et al., 1996).
Furthermore, depletion of p27 using antisense strategies
partially prevents withdrawal from the cell cycle in re-
sponse to mitogen deprivation (Coats et al., 1996; Rivard
et al., 1996). Exit from quiescence after adding growth fac-
tors has been shown to decrease p27 protein levels due to
increased proteasomal degradation of p27 (Pagano et al.,
1995), but other translational mechanisms such as a de-
creased rate of p27 synthesis (Hengst and Reed, 1996;
Agrawal et al., 1996) or a decrease in transcription (Peng
et al., 1996) have also been described. In fibroblasts, ras
signaling through the MAP kinase pathway has been im-
plicated in enhanced p27 degradation (Takuwa and
Takuwa, 1997). Interestingly, p27 is phosphorylated by
MAP kinase in vitro, and phosphorylated p27 shows re-
duced binding to and inhibition of cdk2 (Kawada et al.,
1997; Alessandrini et al., 1997). Phosphorylation of p27 by
cyclin E-cdk2 may also regulate p27 destruction in re-
sponse to mitogens (Sheaff et al., 1997; Vlach et al., 1997).
In our experiments, mitogenic stimulation through abro-
gation of the E-cadherin pathway by SHE78-7 antibody
was dependent on TGF-a signaling. Stimulation by TGF-a
leads to activation of both PI3K and MAPK pathways. In
HT29 cells grown as spheroids, such treatment activates
cellular mitogenesis only after the cells have been disag-
gregated with the neutralizing anti-E-cadherin antibody
with a commensurate decrease in p27 levels. We observed
that both thymidine incorporation and p27 downregula-
tion induced by TGF-a can be blocked by the C225-neu-
tralizing monoclonal anti-EGF receptor-neutralizing anti-
body, the PI3K inhibitor LY29002, and an inhibitor of
superoxide-mediated signaling, NAC, but not by the
MEK-1 inhibitor PD98059. These observations suggest
that the effect of E-cadherin on p27 regulation is indirect,
and possibly involves activation of PI3K and superoxide
signaling via the EGF receptor.
Based on our studies of HT29 cells, it appears that sig-
nals from at least three independent sources impinge on
the cell cycle machinery to regulate proliferation of tumor
cells. First, unlike nontransformed cells, these cells are an-
chorage-independent and grow autonomously in the ab-
sence of exogenously added growth factors. Signaling in
this case appears to be constitutive, and may be the result
of genetic alterations in oncogenes or tumor-suppressor
genes. Indeed, HT29 cells are known to have mutated p53
and APC genes (Huang et al., 1994). Second, adding mito-
gens such as FCS or TGF-a to the growth medium en-
hances the rate of proliferation of HT29 tumor cells. Fi-
nally, results of this study demonstrate that adhesion
mediated by E-cadherin was also a powerful regulator of
growth, repressing mitogenic growth stimulation more
than threefold.
Incomplete Suppression of Tumor Growth
by E-Cadherin
An important finding from these studies is that contact-
dependent growth suppression of tightly adherent tumor
cells, in contrast to normal cells, is incomplete. In fact, we
found it difficult to detect any effect of E-cadherin–neu-
tralizing antibodies on high cell density monolayer cul-
tures of E-cadherin–positive tumor cells, unlike other
studies that have used normal epithelial cells (Takahashi
and Suzuki, 1996; Kandikonda et al., 1996). This discrep-
ancy may be explained by a reduced sensitivity of tumor
cells to undergoing contact-dependent growth inhibition.
However, in a tumor-like three-dimensional context, all
E-cadherin–positive tumor cell lines displayed a signifi-
cant, albeit still incomplete, reduction in cell growth. The
enhanced ability to detect contact-dependent growth inhi-
bition in three-dimensional culture may be due to the fact
that under such conditions tumor cells are exposed to a
relatively greater area of cell surface contact, and conse-
quently may receive a stronger growth inhibitory signal.
Whatever the reasons, these results suggest a need for cau-
tion when studying tumor cell growth exclusively in mono-
layer culture.
Given the ability of E-cadherin to suppress both prolif-
eration and invasion, carcinomas that lose E-cadherin–medi-
ated adhesion either through direct loss of E-cadherin or
indirectly through loss of a- or b-catenin, may acquire a
more aggressive behavior. In that regard, it will be of in-
terest to understand what causes partial loss of contact in-
hibition in cell lines where E-cadherin-dependent adhe-
sion is still observed (Miyaki et al., 1995; Navarro et al.,
1991). One possibility is that transformation induces
changes in the levels or activities of components of the E-cad-
herin system itself, resulting in weaker E-cadherin–medi-
ated adhesion, for example through phosphorylation of
E-cadherin (Stappert and Kemler, 1994) or b-catenin
(Shibamoto et al., 1994). Alternatively, incomplete contact-
dependent growth inhibition may result from loss of a
secondary adhesion mechanism (such as HA-dependent
adhesion), or from the acquisition of constitutive intracel-
lular mitogenic signaling.
The fact that partial E-cadherin function is maintained
in certain tumors and is not selected against despite its
ability to inhibit growth, implies that some level of E-cad-
herin function may be advantageous to tumor cells. For
example, E-cadherin has been shown to protect cells from
undergoing apoptosis or programmed cell death (Her-
miston and Gordon, 1995a; Hermiston and Gordon,
1995b). Thus, in addition to growing more slowly (Miyaki
et al., 1995; Navarro et al., 1991), solid tumors with func-
tional E-cadherin may also be resistant to apoptosis in-
duced by environmental stress (Helmlinger et al., 1997) or
cytotoxic anticancer therapy (Dimanche-Boitrel et al.,
1994; St. Croix and Kerbel, 1997). Even when E-cadherin
adhesion is completely disabled because of a loss of E-cad-
herin, a-catenin, or b-catenin, tumor cells may still display
partial contact-dependent growth inhibition due to the
presence of other adhesion mechanisms such as the HA-The Journal of Cell Biology, Volume 142, 1998 570
dependent mechanism observed in EMT/6 cells. Indeed,
whereas E-cadherin expression is frequently downregu-
lated with tumor progression, many other adhesion mole-
cules are upregulated. These include CD44, CEA (carci-
noembryonic antigen), and ICAM-1 (Jothy et al., 1995;
Johnson, 1991).
In summary, we demonstrate using tumor cells that the
cdk inhibitor p27 plays a significant role in E-cadherin–
dependent growth inhibition. Growth inhibition by cell–
cell adhesion may also help to explain why solid tumors,
despite harboring multiple mutant oncogenes and tumor
suppressor genes, often contain low proliferative fractions
in vivo. E-cadherin can inhibit proliferation by inhibiting
the activity of mitogenic pathways such as the EGFR,
which in turn regulate the level of p27 in cells. E-cadherin–
dependent upregulation of p27 may also help to explain
the widely observed phenomenon of contact inhibition of
normal epithelial cells.
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